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It was planned to evaluate 50 patients present­
ing with symptomatic lesions of the internal ca­
rotid artery.
The inclusion criteria were as follows: age ≥18 
years; 60%–99% stenosis of the internal carotid 
artery; diameter of the target internal carotid ar­
tery ≤7 mm; symptomatic lesion (history of ipsi­
lateral stroke, transient ischemic attack, or revers­
ible ischemic neurological deficit); localization and 
morphology of the lesion enabling surgical ever­
sion endarterectomy or endovascular angioplas­
ty with stenting; and written informed consent.
The exclusion criteria comprised a target le­
sion that has been previously stented or operat­
ed; highly calcified lesions; occlusion of the con­
tralateral carotid artery without adequate collat­
eral circulation through the circle of Willis; ana­
tomical contraindications for eversion endarter­
ectomy; acute ipsilateral stroke; disabling stroke 
at any side; other severe pathologies of the brain, 
resulting in a significant loss of cerebral tissue 
and/or significant neurological deficits; history of 
hemorrhagic transformation of ischemic stroke; 
severe comorbidities; allergy to aspirin, clopido­
grel, or ticlopidine; allergy to iodinated contrast 
media; pregnancy; and metallic implants or other 
known contraindications to magnetic resonance 
imaging. Women of reproductive age who did not 
use effective contraception were also excluded.
Introduction Periprocedural cerebral microembo­
lism associated with carotid artery revasculariza­
tion does not usually manifest as a clinically overt 
stroke. Such microembolism can result in cogni­
tive impairment, which is difficult to measure ob­
jectively. Yet, neuropsychological disturbances 
resulting from these events represent an impor­
tant clinical and socioeconomic problem.1,2 The­
oretically, proximal protection, because of flow 
reversal during endovascular repair,3-10 should 
be associated with a decreased risk of periproce­
dural microembolism when compared with sur­
gical endarterectomy. In this trial, we demon­
strated that there were indeed fewer microem­
bolic cerebral ischemic lesions after stenting with 
a proximal protection device compared with sur­
gical eversion endarterectomy, which—if proven 
by a larger study—would be of particular clini­
cal significance.
Methods CARECarotid (New Ischemic Cere­
bral Lesions After Endarterectomy vs. Stent­
ing for the Treatment of Symptomatic Carotid 
Stenosis) was a prospective randomized single­
­center study, performed at the University Hos­
pital in Kraków, Poland. The study protocol was 
approved by the Bioethical Committee of the Re­
gional Board of Physicians in Kraków (approv­
al no., 137/KBL/OIL/2015) and was registered 
at ClinicalTrials.gov (identifier, NCT03764306). 
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to symptoms of moderate stroke. Similarly, in 
the stent arm, these scores varied from 0 to 5, 
with the mean (SD) score of 2 (1.18). The differ­
ence in the NIHSS score between the study arms 
was not significant.
In all surgical patients, carotid endarterecto­
my was performed using the eversion technique 
and cervical block anesthesia. Shunt was used 
only in 1 patient, as the other patients present­
ed with adequate collateral circulation. All sur­
gical endarterectomies fully restored blood flow 
through the target carotid artery. There were no 
perioperative complications in the surgical arm, 
except for 1 patient who required urgent angio­
plasty and stent implantation due to dissection 
of the target artery, which was localized distally 
to the site of endarterectomy. Endovascular treat­
ment restored proper flow and there were no fur­
ther complications in this patient.
All procedures in the stent arm were performed 
using the Mo.Ma proximal cerebral protection de­
vice (Medtronic, Minneapolis, Minnesota, United 
States). We implanted stents that were tailored 
to the localization of the lesions and morphol­
ogy of the carotid arteries. In the case of rath­
er straight arteries, we used Carotid Wallstent 
stents (Boston Scientific, Massachusetts, Unit­
ed States), while in patients with tortuous arter­
ies, we implanted Precise Pro RX stents (Cordis, 
Fremont, California, United States) or Roadsav­
er stents (Terumo, Tokyo, Japan). Carotid Wall­
stent stents were used in 10 patients; Roadsaver, 
in 5 patients; and Precise Pro RX, in 2 patients. 
There were no technical failures associated with 
stent implantations.
Magnetic resonance imaging Diffusion ­weighted 
magnetic resonance sequences of the brain were 
acquired using a GE 3 Tesla HDx magnetic reso­
nance scanner (GE Healthcare, Chicago, Illinois, 
United States). In both arms of the trial, the im­
aging was performed 1 to 3 days before the pro­
cedure and 2 to 3 days after revascularization. 
The following sequences were acquired: stan­
dard T1 and T2, axial diffusion ­weighted imaging, 
3 ­dimensional time ­of ­flight, and the enhanced 
susceptibility ­weighted angiography. The imag­
es were interpreted by a neuroradiologist who 
was blinded to the procedures. In order to secure 
the blinding, he did not see patients during imag­
ing. Also, in order not to reveal stents, magnetic 
resonance scans did not cover the patients’ necks.
Statistical analysis Categorical variables were 
compared between the groups the χ2 test or 
the extended Mantel–Haenszel χ2 for linear trend 
test. Continuous variables were compared using 
the independent sample t test or, in the case of 
nonnormal distribution, the Mann–Whitney test. 
The significance of the tests was set at a P value 
of less than 0.05.
Results Diffusion ­weighted magnetic reso­
nance imaging before surgical endarterectomy 
It was a randomized study with parallel groups. 
We used closed envelopes as a randomization 
tool. Patients were randomly assigned to one of 
the 2 treatment arms: surgical endarterectomy 
or carotid angioplasty with stenting under prox­
imal protection. All patients provided written 
informed consent to undergo procedures and to 
participate in this trial.
The study was conducted from May 2015 to 
March 2018. During this time, a total of 214 pa­
tients in our center underwent either surgical 
(41 patients) or endovascular treatment (173 pa­
tients) for carotid artery stenosis. However, only 
31 patients met the inclusion and exclusion cri­
teria of this trial. Due to problems with recruit­
ment and also with financing interventional and 
diagnostic procedures, we terminated the study 
before the target number of 50 patients had been 
reached.
Study endpoints The primary endpoint of this 
study was the proportion of patients who had 
new cerebral lesions on magnetic resonance im­
aging 2 to 3 days after the procedure.
Study definitions Patients were considered symp­
tomatic if they had an ipsilateral neurological isch­
emic event during 60 days before the planned pro­
cedure. An ischemic lesion was considered ipsi­
lateral if it occurred in cerebral tissue supplied by 
the target carotid artery. Surgical endarterecto­
my was considered successful if there was no re­
sidual stenosis after the procedure. Endovascu­
lar angioplasty with stenting was considered suc­
cessful if there was no residual stenosis greater 
than 20% and there was no dissection of the tar­
get artery following the procedure.
Patients After randomization, 14 patients were 
assigned to the surgical arm, and 17 patients, to 
the stent arm. The mean (SD) age of patients was 
69 (7.7) years: 70.1 (7.7) years in the surgical arm 
and 68.1 (7.7) years in the stent arm. There were 
no significant differences between the study arms 
regarding age and sex of patients or lateralization 
of the lesions. The mean (SD) length of the target 
lesion was 14.5 (2.5) mm in the surgical arm and 
14.9 (5.9) mm in the stent arm. The mean (SD) 
degree of stenosis, assessed by Doppler sonogra­
phy, computed tomography angiography, or cath­
eter angiography, was 83.2% (5.7%) in the surgi­
cal arm and 91.2% (10.8%) in the stent arm. These 
differences were nonsignificant.
There were no significant differences between 
the groups regarding comorbidities. The medi­
an time from symptoms to the procedure was 10 
days in the stent arm and 12 days in the surgical 
arm. This difference was also nonsignificant and 
was probably associated with a more complex 
preparation of patients for surgical treatment. In 
the surgical arm, the National Institutes of Health 
Stroke Scale (NIHSS) scores varied from 0 to 5. 
The mean (SD) NIHSS score was 1.1 (1.8); thus, 
the neurological status ranged from no stroke 
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endarterectomy.11 Nonetheless, a majority of mi­
croemboli is probably released during dissection 
of the carotid arteries. Novel surgical methods 
focus on no ­touch isolation technique for these 
arteries.12 Perhaps in future studies assessing 
the risk of postprocedural cerebral microembo­
lism, patients should be managed using such a no­
­touch surgical technique.
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1 cm in diameter. There were no significant dif­
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Discussion This prospective randomized trial 
demonstrated that there were fewer new large 
ischemic lesions after endovascular angioplasty 
with stenting with a proximal protection device 
in comparison with surgical eversion endarterec­
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tions of our study. This was a single ­center study 
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